Current advice put forward by CMOs once again shows a blinkered focus on rare typically mild side-effects of vaccines rather than the substantial benefits of vaccines against long COVID. What evidence do they have that 1 dose is the best strategy in terms of benefits vs risks?
Worth noting here that JCVI still haven't released even their limited analysis examining hospitalisations and ICUs despite the CMO yesterday quoting this, and endorsing it? Surely, given these decisions involved children's healths & lives, these calculations should be released.
And an explanation for why long COVID was not considered, despite more than enough evidence that it affects children. It's interesting that they cite 'uncertainty' for a reason not considering it but do consider 'uncertainty' around improbable long-term impacts of vaccination....
Similarly they say they don't consider reduction educational disruption via vaccination, but do discuss disruption due to vaccination in schools (likely to be far far less than disruption due to SARS-CoV-2 transmission!)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
